DENN vs JAZZ · P/E 12, rev $452.3M vs P/E 1988, rev $2.28B
Denny’s Corp (DENN) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Denny’s Corp (DENN) is a restaurants company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported DENN revenue for 2024-12-25 was $452.3M. Net income was $21.6M. Revenue was down 2.5% from 2023-12-27 to 2024-12-25. DENN currently screens at market cap $209.1M and trailing P/E 12.4.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
DENN currently screens at market cap $209.1M and trailing P/E 12.4. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the DENN and JAZZ stock pages for the full models.
Not investment advice.